Molecular remission of Philadelphia/brc-abl-positive acute myeloid leukaemia after treatment with anti-CD 33 calicheamicin conjugate (gemtuzumab ozogamicin, CMA-676)

MP Vetten; JH (Joop) Jansen; BA Reijden; MS Berger; Mark Zijlmans; Bob Löwenberg

doi:10.1046/j.1365-2141.2000.02402.x

Molecular remission of Philadelphia/brc-abl-positive acute myeloid leukaemia after treatment with anti-CD 33 calicheamicin conjugate (gemtuzumab ozogamicin, CMA-676)

MP Vetten, JH (Joop) Jansen, BA Reijden, MS Berger, Mark Zijlmans, Bob Löwenberg

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

17 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	277-279
Number of pages	3
Journal	British Journal of Haematology
Volume	111
DOIs	https://doi.org/10.1046/j.1365-2141.2000.02402.x
Publication status	Published - 2000

Access to Document

10.1046/j.1365-2141.2000.02402.x

http://hdl.handle.net/1765/62302

Cite this

@article{50157b649c414165a6d5ec8609ee6bbb,

title = "Molecular remission of Philadelphia/brc-abl-positive acute myeloid leukaemia after treatment with anti-CD 33 calicheamicin conjugate (gemtuzumab ozogamicin, CMA-676)",

author = "MP Vetten and Jansen, {JH (Joop)} and BA Reijden and MS Berger and Mark Zijlmans and Bob L{\"o}wenberg",

year = "2000",

doi = "10.1046/j.1365-2141.2000.02402.x",

language = "Undefined/Unknown",

volume = "111",

pages = "277--279",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "Wiley-Blackwell Publishing Ltd",

}

Molecular remission of Philadelphia/brc-abl-positive acute myeloid leukaemia after treatment with anti-CD 33 calicheamicin conjugate (gemtuzumab ozogamicin, CMA-676). / Vetten, MP; Jansen, JH (Joop); Reijden, BA; Berger, MS; Zijlmans, Mark; Löwenberg, Bob.

In: British Journal of Haematology, Vol. 111, 2000, p. 277-279.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Molecular remission of Philadelphia/brc-abl-positive acute myeloid leukaemia after treatment with anti-CD 33 calicheamicin conjugate (gemtuzumab ozogamicin, CMA-676)

AU - Vetten, MP

AU - Jansen, JH (Joop)

AU - Reijden, BA

AU - Berger, MS

AU - Zijlmans, Mark

AU - Löwenberg, Bob

PY - 2000

Y1 - 2000

U2 - 10.1046/j.1365-2141.2000.02402.x

DO - 10.1046/j.1365-2141.2000.02402.x

M3 - Article

VL - 111

SP - 277

EP - 279

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

ER -